Clinical Trials Directory

Trials / Conditions / Castration Resistant

Castration Resistant

5 registered clinical trials studyying Castration Resistant — 1 currently recruiting.

StatusTrialSponsorPhase
Terminated64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Ex
NCT05633160
Clarity Pharmaceuticals LtdPhase 1 / Phase 2
RecruitingBipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT04704505
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
UnknownPROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.
NCT02922218
Centro Nacional de Investigaciones Oncologicas CARLOS III—
UnknownPRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.
NCT02925702
Centro Nacional de Investigaciones Oncologicas CARLOS III—
CompletedEfficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant
NCT02200614
BayerPhase 3